Home
Finance
Companies
Industry
Market

SRPT stock

Oppenheimer slashes price target on Sarepta Therapeutics Inc [SRPT] – find out why.

September 17, 2025

Caleb Clifford

Sarepta Therapeutics Inc [NASDAQ: SRPT] surged by $0.63 during the normal trading session on Tuesday and reaching a high of ...

most recent

Industry

Oppenheimer slashes price target on Sarepta Therapeutics Inc [SRPT] – find out why.

Finance

Citigroup lifts Goodyear Tire & Rubber Co [GT] price estimate. Who else is bullish?

Companies

American Resources Corporation [AREC] stock Resumed by D. Boral Capital analyst, price target now $6

Market

Shell Plc ADR [SHEL] is 7.99% higher this YTD. Is it still time to buy?

Finance

Morgan Stanley slashes price target on Amicus Therapeutics Inc [FOLD] – find out why.

Industry

For Roivant Sciences Ltd [ROIV], Analyst sees a rise to $16. What next?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled